Terlipressin

Chemical formula: C₅₂H₇₄N₁₆O₁₅S₂  Molecular mass: 1,227.372 g/mol  PubChem compound: 72081

Therapeutic indications

Terlipressin is indicated for:

Bleeding oesophageal varices

Population group: only adults (18 years old or older)

Bleeding esophageal varices

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Hepatorenal syndrome

Population group: only adults (18 years old or older)

Hepatorenal syndrome

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Terlipressin is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2021: VARIQUEL Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈